Arkolith/Insider Trading/VRCA/Form 4

Zawitz David

Chief Operating OfficerVerrica Pharmaceuticals Inc. (VRCA) · full profile →Form 4 · filed Nov 25, 2025
Net Buying
Open-Market Buys
$42K
Open-Market Sells
$0
Net Open-Market Flow
$42K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 25, 2025Buy(P)10K$4.24$42K21K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 25, 2025Buy(P)3K——3K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002046750-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML